By Deron Hamel Tina Smith has seen the negative impact seizure medication shortages have on people living with epilepsy and their families – she and her son, Nicholas, have lived through it more than once. Fifteen-year-old Nicholas had his first tonic-clonic seizure at seven. In 2009, Nicholas was diagnosed with epilepsy. During the next several…
By Deron Hamel Stakeholders would be better positioned to offer solutions to prevent medication shortages if pharmaceutical companies provided public explanations about why shortages happen, says Suzanne Nurse, Epilepsy Ontario’s director of information and client services. Following public consultation in 2014, the Canadian government announced it would be mandating the country’s pharmaceutical manufacturers to publicly…
By Deron Hamel When it comes to epileptic seizures, it’s safe to say tonic-clonic seizures are the most recognized – and misunderstood – variety. A new video on Epilepsy Ontario’s website provides insight into what tonic-clonic seizures are, what to do if you see someone having this type of seizure and what not to do.…
By Deron Hamel Epilepsy Ontario’s weekly column, the Voices of Epilepsy, saw strong readership in 2015, and of all the issues covered this year one received more buzz on the organization’s social-media platforms than any other: cannabidiol (CBD). CBD is a substance derived from the marijuana plant. It is the most abundant, non-psychoactive chemical compound…
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
